Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06643494
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-10-10
Brief Title:
Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Alleviating Androgen Deprivation Therapy ADT External Beam Radiation EBR Treatment Side Effects in Prostate Cancer Patients
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Does nutraceutical N-111 lower the number of side effects occurring during ADT External Beam Radiation EBR prostate cancer treatment
Detailed Description:
Researchers will compare nutraceutical N-111 to a placebo a look-alike substance that contains no active ingredients and control group to see if N-111 works to alleviate side effects of prostate cancer treatment
Participants will
Take N-111 or a placebo by mouth every day for the duration of the ADT EBR therapy Fill out the self-evaluation reporting form weekly during EBR therapy and every three months during ADT therapy to assess their symptoms or lack of symptoms
The patients will see a physician once a week during the EBR therapy and once every three months for the duration of the ADT therapy
Participants will
Take N-111 or a placebo by mouth every day for the duration of the ADT EBR therapy Fill out the self-evaluation reporting form weekly during EBR therapy and every three months during ADT therapy to assess their symptoms or lack of symptoms
The patients will see a physician once a week during the EBR therapy and once every three months for the duration of the ADT therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None